Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gordon Li

Neurological Surgery Stanford, CA Medical Doctor

NPI 1225218043 CMS profile 996325

300 Pasteur Dr, Stanford, CA 94305

Open in the dashboard

General payments

$49,054

90 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$242,115 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Gordon Li of Stanford, CA is reported in the CMS Open Payments database as having received $49,054 across 90 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $242,115 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,348 21
2024 General $510 12
2023 General $1,260 10
2022 General $1,262 6
2021 General $4,416 9
2020 General $2,984 3
2019 General $27,275 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gordon Li
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Gordon Li were reported at $11,348. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Gordon Li Neurological Surgery median Middle half National median
2019 $27,275 $582 $138–$3,006 $163
2020 $2,984 $294 $76–$2,174 $114
2021 $4,416 $387 $105–$2,432 $132
2022 $1,262 $542 $139–$2,989 $149
2023 $1,260 $534 $145–$2,697 $160
2024 $510 $574 $155–$3,046 $164
2025 $11,348 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $16,925 22 payments
  2. Medtronic, Inc. $15,186 40 payments
  3. Medical Device Business Services, Inc. $14,927 8 payments
  4. Stryker Corporation $991 8 payments
  5. KLS-Martin L.P. $848 9 payments
  6. MicroVention, Inc. $92 1 payment
  7. DePuy Synthes Sales Inc. $45 1 payment
  8. Impel Pharmaceuticals Inc. $39 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $42,483 24 payments
  2. Travel and Lodging $3,308 16 payments
  3. Food and Beverage $3,264 50 payments
Products named General payments · program years 2019–2025
  1. StealthStation Image Guided Surgery Products $12,840 12 payments
  2. MATRIXNEURO CMF-Trauma $12,578 2 payments
  3. CRANIOS REINFORCED $12,578 2 payments
  4. LOW-PROFILE NEURO SYSTEM $12,578 2 payments
  5. CRANIAL FLAP TUBE CLAMPS $12,578 2 payments
  6. STEALTHSTATION S8 PLATFORM $11,227 18 payments
  7. MIDAS REX $3,936 9 payments
  8. StealthStation Image Guided Surgery Products $2,250 4 payments
  9. MATRIXNEURO CMF-Trauma $1,755 1 payment
  10. NA $1,755 1 payment
  11. Other $6,536 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$140,843

Medicare's payments for the services billed

Medicare patients

252

Average age 72

Services billed

514

143 women, 109 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Cancer 38%
Arthritis 37%
Diabetes 27%
Ischemic heart disease 24%
Chronic kidney disease 24%
Depression 21%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

90 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record